Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

NOZINAN DIN 01927647

Status: Cancelled Post Market
Holder: AVENTIS PHARMA INC
Molecule: METHOTRIMEPRAZINE (METHOTRIMEPRAZINE MALEATE)

Health Canada record

Active ingredient(s)METHOTRIMEPRAZINE (METHOTRIMEPRAZINE MALEATE) 2 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCN05AA02 LEVOMEPROMAZINE
Original market date31-Dec-1958
Current status date01-Aug-2005
SourceHealth Canada DPD

Establishment licence of the holder

Aventis Pharma Manufacturing Pte Ltd. — licence , not currently licensed, last inspection rating C (2024-05-09).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing METHOTRIMEPRAZINE (METHOTRIMEPRAZINE MALEATE)

DINProductCompanyFormStrengthStatus
02238405METHOPRAZINEAA PHARMA INCTabletMETHOTRIMEPRAZINE (METHOTRIMEPRAZINE MALEATE) 25 MGMarketed
02238406METHOPRAZINEAA PHARMA INCTabletMETHOTRIMEPRAZINE (METHOTRIMEPRAZINE MALEATE) 50 MGMarketed
02238403METHOPRAZINEAA PHARMA INCTabletMETHOTRIMEPRAZINE (METHOTRIMEPRAZINE MALEATE) 2 MGMarketed
02238404METHOPRAZINEAA PHARMA INCTabletMETHOTRIMEPRAZINE (METHOTRIMEPRAZINE MALEATE) 5 MGMarketed
02239632METHOTRIMEPRAZINE-2PRO DOC LIMITEETabletMETHOTRIMEPRAZINE (METHOTRIMEPRAZINE MALEATE) 2 MGCancelled Post Market
02239634METHOTRIMEPRAZINE-25PRO DOC LIMITEETabletMETHOTRIMEPRAZINE (METHOTRIMEPRAZINE MALEATE) 25 MGCancelled Post Market
02239633METHOTRIMEPRAZINE-5PRO DOC LIMITEETabletMETHOTRIMEPRAZINE (METHOTRIMEPRAZINE MALEATE) 5 MGCancelled Post Market
02239635METHOTRIMEPRAZINE-50PRO DOC LIMITEETabletMETHOTRIMEPRAZINE (METHOTRIMEPRAZINE MALEATE) 50 MGCancelled Post Market
01964933NOV MEPRAZINE TAB 50MGNOVOPHARM LIMITEDTabletMETHOTRIMEPRAZINE (METHOTRIMEPRAZINE MALEATE) 50 MGCancelled Post Market
01964925NOVO MEPRAZINE TAB 25MGNOVOPHARM LIMITEDTabletMETHOTRIMEPRAZINE (METHOTRIMEPRAZINE MALEATE) 25 MGCancelled Post Market
01964909NOVO MEPRAZINE TAB 5MGNOVOPHARM LIMITEDTabletMETHOTRIMEPRAZINE (METHOTRIMEPRAZINE MALEATE) 5 MGCancelled Post Market
01927655NOZINANSANOFI-AVENTIS CANADA INCTabletMETHOTRIMEPRAZINE (METHOTRIMEPRAZINE MALEATE) 5 MGCancelled Post Market
01927663NOZINANSANOFI-AVENTIS CANADA INCTabletMETHOTRIMEPRAZINE (METHOTRIMEPRAZINE MALEATE) 25 MGCancelled Post Market
01927671NOZINANSANOFI-AVENTIS CANADA INCTabletMETHOTRIMEPRAZINE (METHOTRIMEPRAZINE MALEATE) 50 MGCancelled Post Market
02232905PMS-METHOTRIMEPRAZINEPHARMASCIENCE INCTabletMETHOTRIMEPRAZINE (METHOTRIMEPRAZINE MALEATE) 50 MGCancelled Post Market
02232904PMS-METHOTRIMEPRAZINEPHARMASCIENCE INCTabletMETHOTRIMEPRAZINE (METHOTRIMEPRAZINE MALEATE) 25 MGCancelled Post Market
02232903PMS-METHOTRIMEPRAZINEPHARMASCIENCE INCTabletMETHOTRIMEPRAZINE (METHOTRIMEPRAZINE MALEATE) 5 MGCancelled Post Market
02241197RIVA-MEPRAZINE 25MG TABLETSLABORATOIRE RIVA INC.TabletMETHOTRIMEPRAZINE (METHOTRIMEPRAZINE MALEATE) 25 MGCancelled Post Market
02241198RIVA-MEPRAZINE 50MG TABLETSLABORATOIRE RIVA INC.TabletMETHOTRIMEPRAZINE (METHOTRIMEPRAZINE MALEATE) 50 MGCancelled Post Market
02241199RIVA-MEPRAZINE 5MG TABLETSLABORATOIRE RIVA INC.TabletMETHOTRIMEPRAZINE (METHOTRIMEPRAZINE MALEATE) 5 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
12832000-11-14New Drug Submission (NDS)
Request a quote for NOZINAN

How to read a Canadian DIN record